For: | Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 2004; 10(23): 3441-3454 [PMID: 15526363 DOI: 10.3748/wjg.v10.i23.3441] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i23/3441.htm |
Number | Citing Articles |
1 |
Edward J. Fox, Dermot T. Leahy, Robert Geraghty, Hugh E. Mulcahy, David Fennelly, John M. Hyland, Diarmuid P. O'Donoghue, Kieran Sheahan. Mutually Exclusive Promoter Hypermethylation Patterns of hMLH1 and O-Methylguanine DNA Methyltransferase in Colorectal Cancer. The Journal of Molecular Diagnostics 2006; 8(1): 68 doi: 10.2353/jmoldx.2006.050084
|
2 |
Augusto Villanueva, Derek Y. Chiang, Pippa Newell, Judit Peix, Swan Thung, Clara Alsinet, Victoria Tovar, Sasan Roayaie, Beatriz Minguez, Manel Sole, Carlo Battiston, Stijn van Laarhoven, Maria I. Fiel, Analisa Di Feo, Yujin Hoshida, Steven Yea, Sara Toffanin, Alex Ramos, John A. Martignetti, Vincenzo Mazzaferro, Jordi Bruix, Samuel Waxman, Myron Schwartz, Matthew Meyerson, Scott L. Friedman, Josep M. Llovet. Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma. Gastroenterology 2008; 135(6): 1972 doi: 10.1053/j.gastro.2008.08.008
|
3 |
Shinji Maegawa, George Hinkal, Hyun Soo Kim, Lanlan Shen, Li Zhang, Jiexin Zhang, Nianxiang Zhang, Shoudan Liang, Lawrence A. Donehower, Jean-Pierre J. Issa. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Research 2010; 20(3): 332 doi: 10.1101/gr.096826.109
|
4 |
Marco A. De Velasco, Kazuko Sakai, Seiichiro Mitani, Yurie Kura, Shuji Minamoto, Takahiro Haeno, Hidetoshi Hayashi, Kazuto Nishio. A machine learning-based method for feature reduction of methylation data for the classification of cancer tissue origin. International Journal of Clinical Oncology 2024; 29(12): 1795 doi: 10.1007/s10147-024-02617-w
|
5 |
Zhi Rong Qian, Toshiaki Sano, Katsuhiko Yoshimoto, Sylvia L Asa, Shozo Yamada, Noriko Mizusawa, Eiji Kudo. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Modern Pathology 2007; 20(12): 1269 doi: 10.1038/modpathol.3800965
|
6 |
H Y Chen, J Y Hu, T H Chen, Y C Lin, X Liu, M Y Lin, Y D Lang, Y Yen, R H Chen. KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination. Oncogene 2015; 34(40): 5141 doi: 10.1038/onc.2014.435
|
7 |
Ramesh P Arasaradnam, M Nabil Quraishi, Daniel Commane, John C Mathers, Mike Bradburn. MYOD-1 in normal colonic mucosa – role as a putative biomarker?. BMC Research Notes 2012; 5(1) doi: 10.1186/1756-0500-5-240
|
8 |
Shuji Ogino, Takako Kawasaki, Gregory J Kirkner, Taiki Yamaji, Massimo Loda, Charles S Fuchs. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Modern Pathology 2007; 20(1): 15 doi: 10.1038/modpathol.3800709
|
9 |
Kateřina Vašíčková, Peter Horak, Petr Vaňhara. TUSC3: functional duality of a cancer gene. Cellular and Molecular Life Sciences 2018; 75(5): 849 doi: 10.1007/s00018-017-2660-4
|
10 |
Chiara Molinari, Valentina Casadio, Flavia Foca, Chiara Zingaretti, Massimo Giannini, Andrea Avanzolini, Enrico Lucci, Luca Saragoni, Alessandro Passardi, Dino Amadori, Daniele Calistri, Wainer Zoli. Gene methylation in rectal cancer: Predictive marker of response to chemoradiotherapy?. Journal of Cellular Physiology 2013; 228(12): 2343 doi: 10.1002/jcp.24405
|
11 |
Giulia Magnani, Daniela Furlan, Nora Sahnane, Luca Reggiani Bonetti, Federica Domati, Monica Pedroni. Molecular Features and Methylation Status in Early Onset (≤40 Years) Colorectal Cancer: A Population Based, Case-Control Study. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/132190
|
12 |
D. A. Rasskazov, E. V. Antontseva, L. O. Bryzgalov, M. Yu. Matveeva, E. V. Kashina, P. M. Ponomarenko, G. V. Orlova, M. P. Ponomarenko, D. A. Afonnikov, T. I. Merkulova. rSNP_Guide-based evaluation of SNPs in promoters of the human APC and MLH1 genes associated with colon cancer. Russian Journal of Genetics: Applied Research 2014; 4(4): 245 doi: 10.1134/S2079059714040108
|
13 |
Gerda C. Leitner, Martin Faschingbauer, Sabine Wenda, Günter Weigel, Gottfried Fischer. Administration of recombinant human granulocyte–colony‐stimulating factor does not induce long‐lasting detectable epigenetic alterations in healthy donors. Transfusion 2014; 54(12): 3121 doi: 10.1111/trf.12732
|
14 |
Filiz Ozen, Metin Sen, Ozturk Ozdemir. Methylenetetrahydrofolate Reductase Gene Germ-Line C677T and A1298C SNPs are Associated with Colorectal Cancer Risk in the Turkish Population. Asian Pacific Journal of Cancer Prevention 2014; 15(18): 7731 doi: 10.7314/APJCP.2014.15.18.7731
|
15 |
Dong Wang, Yao Xu, Xin Geng, Weiming Zhang. Analysis of inactivation of hMLH1 by promoter hypermethylation and microsatellite instability in gastric carcinogenesis. Chinese Journal of Clinical Oncology 2006; 3(2): 102 doi: 10.1007/s11805-006-0082-4
|
16 |
Myoung Sook Kim, Juna Lee, David Sidransky. DNA methylation markers in colorectal cancer. Cancer and Metastasis Reviews 2010; 29(1): 181 doi: 10.1007/s10555-010-9207-6
|
17 |
Sohail A. Qureshi, Muhammed Umair Bashir, Ahmed Yaqinuddin. Utility of DNA methylation markers for diagnosing cancer. International Journal of Surgery 2010; 8(3): 194 doi: 10.1016/j.ijsu.2010.02.001
|
18 |
Zhenshu Wen, Zhi-Ping Liu, Zhengrong Liu, Yan Zhang, Luonan Chen. An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer. Journal of the American Medical Informatics Association 2013; 20(4): 659 doi: 10.1136/amiajnl-2012-001168
|
19 |
Yu-Cai Wang, Zheng-Hong Yu, Chang Liu, Li-Zhi Xu, Wen Yu, Jia Lu, Ren-Min Zhu, Guo-Li Li, Xin-Yi Xia, Xiao-Wei Wei, Hong-Zan Ji, Heng Lu, Yong Gao, Wei-Min Gao, Long-Bang Chen. Detection of <italic>RASSF1A</italic> promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World Journal of Gastroenterology 2008; 14(19): 3074-3080 doi: 10.3748/wjg.14.3074
|
20 |
Naser Amirizadeh, Arezoo Oodi, Mahin Nikougoftar, Mohamad Soleiman Soltanpour. Expression and promoter methylation changes of the P15INK4bduringex vivocord blood CD34+cell expansion following co-culture with mesenchymal stromal cells. Hematology 2013; 18(5): 260 doi: 10.1179/1607845412Y.0000000062
|
21 |
Elizabeth Vincan, Nick Barker. The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression. Clinical & Experimental Metastasis 2008; 25(6): 657 doi: 10.1007/s10585-008-9156-4
|
22 |
William Tzu-Liang Chen, Sheng-Chi Chang, Tao-Wei Ke, Hua-Che Chiang, Fuu-Jen Tsai, Wan-Yu Lo. Identification of biomarkers to improve diagnostic sensitivity of sporadic colorectal cancer in patients with low preoperative serum carcinoembryonic antigen by clinical proteomic analysis. Clinica Chimica Acta 2011; 412(7-8): 636 doi: 10.1016/j.cca.2010.12.024
|
23 |
Carolina Bernal, Francisco Aguayo, Cynthia Villarroel, Macarena Vargas, Ignacio Díaz, Francisco J. Ossandon, Eudocia Santibáñez, Mariana Palma, Edmundo Aravena, Carlos Barrientos, Alejandro H. Corvalan.
Reprimo as a Potential Biomarker for Early Detection in Gastric Cancer. Clinical Cancer Research 2008; 14(19): 6264 doi: 10.1158/1078-0432.CCR-07-4522
|
24 |
Myoung Sook Kim, Joost Louwagie, Beatriz Carvalho, Jochim S. Terhaar sive Droste, Hannah Lui Park, Young Kwang Chae, Keishi Yamashita, Junwei Liu, Kimberly Laskie Ostrow, Shizhang Ling, Rafael Guerrero-Preston, Semra Demokan, Zubeyde Yalniz, Nejat Dalay, Gerrit A. Meijer, Wim Van Criekinge, David Sidransky, Jonathan Weitzman. Promoter DNA Methylation of Oncostatin M receptor-β as a Novel Diagnostic and Therapeutic Marker in Colon Cancer. PLoS ONE 2009; 4(8): e6555 doi: 10.1371/journal.pone.0006555
|
25 |
Bin Yang, Shuai Miao, Le-Ning Zhang, Hong-Bin Sun, Zhe-Nan Xu, Chun-Shan Han. Correlation ofCCNA1Promoter Methylation with Malignant Tumors: A Meta-Analysis Introduction. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/134027
|
26 |
Tasmina Ferdous Susmi, Atikur Rahman, Md. Moshiur Rahman Khan, Farzana Yasmin, Md. Shariful Islam, Omaima Nasif, Sulaiman Ali Alharbi, Gaber El-Saber Batiha, Mohammad Uzzal Hossain. Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08332-3
|
27 |
A. H. Wu, K. D. Siegmund, T. I. Long, W. Cozen, P. Wan, C.-C. Tseng, D. Shibata, P. W. Laird. Hormone therapy, DNA methylation and colon cancer. Carcinogenesis 2010; 31(6): 1060 doi: 10.1093/carcin/bgq009
|
28 |
L Benetatos, A Dasoula, N Syed, E Hatzimichael, T Crook, K L Bourantas. Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromes. Leukemia 2008; 22(6): 1293 doi: 10.1038/sj.leu.2405053
|
29 |
Wuling Liu, Babu Gajendran, Klarke M. Sample, Chunlin Wang, Anling Hu, Beiling Chen, Yanmei Li, Eldad Zacksenhaus, Yaacov Ben-David. A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer. Cancer Gene Therapy 2022; 29(11): 1590 doi: 10.1038/s41417-022-00471-4
|
30 |
Jing De ZHU. The altered DNA methylation pattern and its implications in liver cancer. Cell Research 2005; 15(4): 272 doi: 10.1038/sj.cr.7290296
|
31 |
Geoffrey S Ginsburg, Susanne B Haga. Translating genomic biomarkers into clinically useful diagnostics. Expert Review of Molecular Diagnostics 2006; 6(2): 179 doi: 10.1586/14737159.6.2.179
|
32 |
Tie-Jun Liang, Hong-Xu Wang, Yan-Yan Zheng, Ying-Qing Cao, Xiaoyu Wu, Xin Zhou, Shu-Xiao Dong. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review. Oncotarget 2017; 8(28): 46468 doi: 10.18632/oncotarget.17576
|
33 |
Arezoo Oodi, Mehrdad Noruzinia, Mehryar Habibi Roudkenar, Mahin Nikougoftar, Mohamad Soleiman Soltanpour, Mona Khorshidfar, Naser Amirizadeh. Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells. Hematology 2012; 17(6): 334 doi: 10.1179/1607845412Y.0000000009
|
34 |
Rania Abdelmaksoud-Dammak, Imen Miladi-Abdennadher, Amena Saadallah-Kallel, Abdelmajid Khabir, Tahia Sellami-Boudawara, Mounir Frikha, Jamel Daoud, Raja Mokdad-Gargouri. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance. Tumor Biology 2014; 35(8): 7975 doi: 10.1007/s13277-014-2015-9
|
35 |
Ugur Deligezer, Nilgün Erten, Ebru E. Akisik, Nejat Dalay. Methylation of the INK4A/ARF locus in blood mononuclear cells. Annals of Hematology 2006; 85(2): 102 doi: 10.1007/s00277-005-0041-9
|
36 |
Stefano La Rosa, Alessandro Marando, Daniela Furlan, Nora Sahnane, Carlo Capella. Colorectal Poorly Differentiated Neuroendocrine Carcinomas and Mixed Adenoneuroendocrine Carcinomas. American Journal of Surgical Pathology 2012; 36(4): 601 doi: 10.1097/PAS.0b013e318242e21c
|
37 |
Xiaoqiang Fan, Xiu Zhang, Jie Shen, Haibin Zhao, Xuetao Yu, Yong’an Chen, Zhuonan Zhuang, Xiaolong Deng, Hua Feng, Yunfei Wang, Long Peng, Aamir Ahmad. Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis. PLOS ONE 2016; 11(2): e0149028 doi: 10.1371/journal.pone.0149028
|
38 |
Young-Ju Woo, Kyung Lib Jang. All-trans retinoic acid activates E-cadherin expression via promoter hypomethylation in the human colon carcinoma HCT116 cells. Biochemical and Biophysical Research Communications 2012; 425(4): 944 doi: 10.1016/j.bbrc.2012.08.038
|
39 |
Tatiana V. Karpinets, Brent D. Foy. Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations. Carcinogenesis 2005; 26(8): 1323 doi: 10.1093/carcin/bgi079
|
40 |
Mehmet Şahin, Emel Şahin, Saadet Gümüşlü, Abdullah Erdoğan, Meral Gültekin. DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability. Cancer and Metastasis Reviews 2010; 29(4): 655 doi: 10.1007/s10555-010-9253-0
|
41 |
Barbara Pardini, Rajiv Kumar, Alessio Naccarati, Rashmi B. Prasad, Asta Forsti, Veronika Polakova, Ludmila Vodickova, Jan Novotny, Kari Hemminki, Pavel Vodicka. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case–control study from the Czech Republic. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2011; 721(1): 74 doi: 10.1016/j.mrgentox.2010.12.008
|
42 |
Anshu Agrawal, Richard F Murphy, Devendra K Agrawal. DNA methylation in breast and colorectal cancers. Modern Pathology 2007; 20(7): 711 doi: 10.1038/modpathol.3800822
|
43 |
Diego F. Calvisi, Sara Ladu, Federico Pinna, Maddalena Frau, Maria L. Tomasi, Marcella Sini, Maria M. Simile, Piero Bonelli, Maria R. Muroni, Maria A. Seddaiu, Dae–Sik Lim, Francesco Feo, Rosa M. Pascale. SKP2 and CKS1 Promote Degradation of Cell Cycle Regulators and Are Associated With Hepatocellular Carcinoma Prognosis. Gastroenterology 2009; 137(5): 1816 doi: 10.1053/j.gastro.2009.08.005
|
44 |
Ismael Reyes, Niradiz Reyes, Robert Suriano, Codrin Iacob, Nina Suslina, Anthony Policastro, Augustine Moscatello, Stimson Schantz, Raj K. Tiwari, Jan Geliebter. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomarkers 2019; 24(1): 71 doi: 10.3233/CBM-181758
|
45 |
Pablo Letelier, Priscilla Brebi, Oscar Tapia, Juan Carlos Roa. DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. Clinical Epigenetics 2012; 4(1) doi: 10.1186/1868-7083-4-11
|
46 |
Moustafa Berrichi, Aziz Hichami, Lynda Addou-Klouche, Amira Sayed Khan, Naim Akhtar Khan. CD36 and GPR120 Methylation Associates with Orosensory Detection Thresholds for Fat and Bitter in Algerian Young Obese Children. Journal of Clinical Medicine 2020; 9(6): 1956 doi: 10.3390/jcm9061956
|
47 |
Juan C. Conde-Pérezprina, Armando Luna-López, Norma E. López-Diazguerrero, Pablo Damián-Matsumura, Alejandro Zentella, Mina Königsberg. Msh2 promoter region hypermethylation as a marker of aging-related deterioration in old retired female breeder mice. Biogerontology 2008; 9(5): 325 doi: 10.1007/s10522-008-9144-8
|
48 |
Lucia Migliore, Francesca Migheli, Roberto Spisni, Fabio Coppedè, Nathan A. Ellis. Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer. BioMed Research International 2011; 2011(1) doi: 10.1155/2011/792362
|
49 |
Muriel XG Draht, Robert R Riedl, Hanneke Niessen, Beatriz Carvalho, Gerrit A Meijer, James G Herman, Manon van Engeland, Veerle Melotte, Kim M Smits. Promoter CpG Island Methylation Markers in Colorectal Cancer: The Road Ahead. Epigenomics 2012; 4(2): 179 doi: 10.2217/epi.12.9
|
50 |
Jun Zhu, Suyu Hao, Xinyue Zhang, Jingyue Qiu, Qin Xuan, Liping Ye. Integrated Bioinformatics Analysis Exhibits Pivotal Exercise-Induced Genes and Corresponding Pathways in Malignant Melanoma. Frontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.637320
|
51 |
Michael Schnekenburger, Marc Diederich. Epigenetics Offer New Horizons for Colorectal Cancer Prevention. Current Colorectal Cancer Reports 2012; 8(1): 66 doi: 10.1007/s11888-011-0116-z
|
52 |
Rania Abdelmaksoud-Dammak, Amena Saadallah-Kallel, Imen Miladi-Abdennadher, Lobna Ayedi, Abdelmajid Khabir, Tahia Sallemi-Boudawara, Mounir Frikha, Jamel Daoud, Raja Mokdad-Gargouri. CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer. Tumor Biology 2016; 37(2): 1707 doi: 10.1007/s13277-015-3902-4
|
53 |
Wenji Yan, Mingzhou Guo. Cancer Epigenetics. Methods in Molecular Biology 2015; 1238: 405 doi: 10.1007/978-1-4939-1804-1_22
|
54 |
S Ogino, T Kawasaki, GJ Kirkner, A Ogawa, I Dorfman, M Loda, CS Fuchs. Down‐regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. The Journal of Pathology 2006; 210(2): 147 doi: 10.1002/path.2030
|
55 |
Jose I. Martin-Subero, Ole Ammerpohl, Marina Bibikova, Eliza Wickham-Garcia, Xabier Agirre, Sara Alvarez, Monika Brüggemann, Stefanie Bug, Maria J. Calasanz, Martina Deckert, Martin Dreyling, Ming Q. Du, Jan Dürig, Martin J. S. Dyer, Jian-Bing Fan, Stefan Gesk, Martin-Leo Hansmann, Lana Harder, Sylvia Hartmann, Wolfram Klapper, Ralf Küppers, Manuel Montesinos-Rongen, Inga Nagel, Christiane Pott, Julia Richter, José Román-Gómez, Marc Seifert, Harald Stein, Javier Suela, Lorenz Trümper, Inga Vater, Felipe Prosper, Claudia Haferlach, Juan Cruz Cigudosa, Reiner Siebert, Syed A. Aziz. A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms. PLoS ONE 2009; 4(9): e6986 doi: 10.1371/journal.pone.0006986
|
56 |
Yuichiro Hatano, Katsunori Semi, Kyoichi Hashimoto, Myeong Sup Lee, Akihiro Hirata, Hiroyuki Tomita, Toshiya Kuno, Manabu Takamatsu, Koji Aoki, Makoto M Taketo, Young-Joon Kim, Akira Hara, Yasuhiro Yamada. Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation. Carcinogenesis 2015; 36(7): 719 doi: 10.1093/carcin/bgv060
|
57 |
DanBo Wang, Qi Chen, ChiYuan Zhang, Fang Ren, Tong Li. DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis. European Journal of Medical Research 2012; 17(1) doi: 10.1186/2047-783X-17-12
|
58 |
Abolfazl Yari, Seyed Mahdi Emami Meybodi, Zahra Miri Karam, Arash Samoudi, Fatemeh Hashemi, Mostafa Aalipour, Maryam Fekri Soofi Abadi, Shahriar Dabiri. Association of MTHFR 677C>T and 1298A>C genetic polymorphisms with colorectal cancer: Genotype and haplotype analysis in a Southeast Iranian population. Gene Reports 2021; 25: 101399 doi: 10.1016/j.genrep.2021.101399
|
59 |
Nakarin Kitkumthorn, Pattamawadee Yanatatsanajit, Sorapop Kiatpongsan, Chureerat Phokaew, Surang Triratanachat, Prasert Trivijitsilp, Wichai Termrungruanglert, Damrong Tresukosol, Somchai Niruthisard, Apiwat Mutirangura. Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-55
|
60 |
Guoxiang Cai, Ye Xu, Hongfen Lu, Yingqiang Shi, Peng Lian, Junjie Peng, Xiang Du, Xiaoyan Zhou, Zuqing Guan, Daren Shi, Sanjun Cai. Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers. International Journal of Colorectal Disease 2008; 23(4): 365 doi: 10.1007/s00384-007-0423-7
|
61 |
Eleftheria Hatzimichael, George Dranitsaris, Aggeliki Dasoula, Leonidas Benetatos, Justin Stebbing, Tim Crook, Konstantinos L. Bourantas. von Hippel–Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone Disease. Clinical Lymphoma and Myeloma 2009; 9(3): 239 doi: 10.3816/CLM.2009.n.047
|
62 |
Xinshuang Yu, Chunjuan Zhai, Yujun Fan, Jiandong Zhang, Ning Liang, Fengjun Liu, Lili Cao, Jia Wang, Juan Du. TUSC3: a novel tumour suppressor gene and its functional implications. Journal of Cellular and Molecular Medicine 2017; 21(9): 1711 doi: 10.1111/jcmm.13128
|
63 |
Qionglin Huang, Qingjin Yang, Mingming Mo, Xiaoxia Ye, Junjie Zhang, Lijian Zhang, Bin Chen, Jian Li, Chun Cai. Screening of exon methylation biomarkers for colorectal cancer via LC‐MS/MS strategy. Journal of Mass Spectrometry 2017; 52(12): 860 doi: 10.1002/jms.4032
|
64 |
Sacide Pehlivan, Mehmet Artac, Tugce Sever, Hakan Bozcuk, Can Kilincarslan, Mustafa Pehlivan. Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer. Cancer Genetics and Cytogenetics 2010; 201(2): 128 doi: 10.1016/j.cancergencyto.2010.05.019
|
65 |
Robert M. Mader. Links between Biology, Prognosis and Prediction of Response to Chemotherapy in Colorectal Cancer. Oncology Research and Treatment 2006; 29(7): 334 doi: 10.1159/000093603
|
66 |
Wei Jin, Yang Liu, Li Chen, Hua Zhu, Gen-hong Di, Hong Ling, Jiong Wu, Zhi-ming Shao. Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Research and Treatment 2011; 125(3): 699 doi: 10.1007/s10549-010-0876-1
|
67 |
C. Kurkjian, S. Kummar, A.J. Murgo. DNA Methylation: Its Role in Cancer Development and Therapy. Current Problems in Cancer 2008; 32(5): 187 doi: 10.1016/j.currproblcancer.2008.08.002
|
68 |
Alessandro Lugli, Inti Zlobec. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures. 2012; : 115 doi: 10.1007/978-1-61779-358-5_8
|
69 |
John Lynch, Anil K. Rustgi. Physiology of the Gastrointestinal Tract. 2006; : 477 doi: 10.1016/B978-012088394-3/50020-9
|
70 |
Fei Hu, Li Chen, Ming-Yu Bi, Ling Zheng, Ji-Xiang He, Ying-Ze Huang, Yu Zhang, Xue-Lian Zhang, Qiang Guo, Ying Luo, Wen-Ru Tang, Miao-Miao Sheng. Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: Meta-analysis and TCGA analysis. Pathology - Research and Practice 2020; 216(8): 153009 doi: 10.1016/j.prp.2020.153009
|
71 |
John P. Lynch, Anil K. Rustgi. Physiology of the Gastrointestinal Tract. 2012; : 2129 doi: 10.1016/B978-0-12-382026-6.00080-4
|
72 |
Zahra Mohammadi, Mehdi Azad, Farshad Foroughi, Sahar Khojastehpour, Nematollah Gheibi, Fatemeh Samiee-Rad, Amirhosein Maali, Mohammad Hossein Ahmadi. Evaluation of expression level and methylation profile of CXX1 gene in breast cancer tissue blocks. Journal of Cancer Research and Therapeutics 2021; 17(6): 1328 doi: 10.4103/jcrt.JCRT_27_20
|
73 |
Ning Li, Jun‐Fang Qin, Xiao Han, Feng‐Jiao Jin, Jia‐Hui Zhang, Lan Lan, Yue Wang. miR‐21a negatively modulates tumor suppressor genes PTEN and miR‐200c and further promotes the transformation of M2 macrophages. Immunology & Cell Biology 2018; 96(1): 68 doi: 10.1111/imcb.1016
|
74 |
Dimitra Dafou, Susan J. Ramus, Ken Choi, Barbara Grun, Deborah A. Trott, Robert F. Newbold, Ian J. Jacobs, Christopher Jones, Simon A. Gayther. Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells. International Journal of Cancer 2009; 124(5): 1037 doi: 10.1002/ijc.24058
|
75 |
Barbara Delage, Roderick Dashwood. Dietary Modulation of Cell Signaling Pathways. Oxidative Stress and Disease 2008; 20083666 doi: 10.1201/9780849381492.ch13
|
76 |
Patricia García, Carlos Manterola, Juan Carlos Araya, Miguel Villaseca, Pablo Guzmán, Antonio Sanhueza, Melanie Thomas, Héctor Alvarez, Juan Carlos Roa. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions. Molecular Carcinogenesis 2009; 48(1): 79 doi: 10.1002/mc.20457
|
77 |
Chi Chun Wong, Weilin Li, Bertina Chan, Jun Yu. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers. Seminars in Cancer Biology 2019; 55: 90 doi: 10.1016/j.semcancer.2018.04.002
|
78 |
Nicola Valeri, Chiara Braconi, Pierluigi Gasparini, Claudio Murgia, Andrea Lampis, Viola Paulus-Hock, Jonathan R. Hart, Lynn Ueno, Sergei I. Grivennikov, Francesca Lovat, Alessio Paone, Luciano Cascione, Khlea M. Sumani, Angelo Veronese, Muller Fabbri, Stefania Carasi, Hansjuerg Alder, Giovanni Lanza, Roberta Gafa’, Mary P. Moyer, Rachel A. Ridgway, Julia Cordero, Gerard J. Nuovo, Wendy L. Frankel, Massimo Rugge, Matteo Fassan, Joanna Groden, Peter K. Vogt, Michael Karin, Owen J. Sansom, Carlo M. Croce. MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer. Cancer Cell 2014; 25(4): 469 doi: 10.1016/j.ccr.2014.03.006
|
79 |
Antonia R. Sepulveda, John P. Lynch. Cancer Genome and Tumor Microenvironment. 2010; : 351 doi: 10.1007/978-1-4419-0711-0_16
|
80 |
Taina T. Nieminen, Soheir Shoman, Saad Eissa, Päivi Peltomäki, Wael M. Abdel-Rahman. Distinct Genetic and Epigenetic Signatures of Colorectal Cancers According to Ethnic Origin. Cancer Epidemiology, Biomarkers & Prevention 2012; 21(1): 202 doi: 10.1158/1055-9965.EPI-11-0662
|
81 |
Alessio Naccarati, Barbara Pardini, Kari Hemminki, Pavel Vodicka. Sporadic colorectal cancer and individual susceptibility: A review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutation Research/Reviews in Mutation Research 2007; 635(2-3): 118 doi: 10.1016/j.mrrev.2007.02.001
|
82 |
G.L. Wiesner, T.P. Slavin, J.S. Barnholtz-Sloan. Essentials of Genomic and Personalized Medicine. 2010; : 457 doi: 10.1016/B978-0-12-374934-5.00036-2
|
83 |
Laura J Gay, Panagiota N Mitrou, Jennifer Keen, Richard Bowman, Adam Naguib, James Cooke, Gunter G Kuhnle, Philip A Burns, Robert Luben, Marleen Lentjes, Kay‐Tee Khaw, Richard Y Ball, Ashraf EK Ibrahim, Mark J Arends. Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC‐Norfolk study. The Journal of Pathology 2012; 228(3): 405 doi: 10.1002/path.4085
|
84 |
Nicola Potter, Aikaterini Karakoula, Kim P. Phipps, William Harkness, Richard Hayward, Dominic N.P. Thompson, Thomas S. Jacques, Brian Harding, David G.T. Thomas, Rodger W. Palmer, Jeremy Rees, John Darling, Tracy J. Warr. Genomic Deletions Correlate with Underexpression of Novel Candidate Genes at Six Loci in Pediatric Pilocytic Astrocytoma. Neoplasia 2008; 10(8): 757 doi: 10.1593/neo.07914
|
85 |
Dietmar Pils, Peter Horak, Petr Vanhara, Mariam Anees, Michaela Petz, Angela Alfanz, Alfred Gugerell, Michael Wittinger, Andreas Gleiss, Veronika Auner, Dan Tong, Robert Zeillinger, Elena‐Ioana Braicu, Jalid Sehouli, Michael Krainer. Methylation status of TUSC3 is a prognostic factor in ovarian cancer. Cancer 2013; 119(5): 946 doi: 10.1002/cncr.27850
|
86 |
Arezoo Oodi, Hamed Norouzi, Naser Amirizadeh, Mahin Nikougoftar, Zahra Vafaie. Harmine, a Novel DNA Methyltransferase 1 Inhibitor in the Leukemia Cell Line. Indian Journal of Hematology and Blood Transfusion 2017; 33(4): 509 doi: 10.1007/s12288-016-0770-z
|
87 |
Maria Philippova, Manjunath B. Joshi, Emmanouil Kyriakakis, Dennis Pfaff, Paul Erne, Therese J. Resink. A guide and guard: The many faces of T-cadherin. Cellular Signalling 2009; 21(7): 1035 doi: 10.1016/j.cellsig.2009.01.035
|
88 |
Bian Shi, Junfeng Chu, Qilong Gao, Tongde Tian. Promoter methylation of human mutL homolog 1 and colorectal cancer risk. Journal of Cancer Research and Therapeutics 2018; 14(4): 851 doi: 10.4103/0973-1482.172587
|
89 |
Hassan Ashktorab, Hamed Rahi, Daniel Wansley, Sudhir Varma, Babak Shokrani, Edward Lee, Mohammad Daremipouran, Adeyinka Laiyemo, Ajay Goel, John M Carethers, Hassan Brim. Toward a comprehensive and systematic methylome signature in colorectal cancers. Epigenetics 2013; 8(8): 807 doi: 10.4161/epi.25497
|
90 |
G.L. Wiesner, T.P. Slavin, J.S. Barnholtz-Sloan. Genomic and Personalized Medicine. 2009; : 879 doi: 10.1016/B978-0-12-369420-1.00073-1
|
91 |
Naser Amirizadeh, Arezoo Oodi, Roya Mehrasa, Mahin Nikougoftar. Apoptosis, DAP-Kinase1 Expression and the Influences of Cytokine Milieu and Mesenchymal Stromal Cells on Ex Vivo Expansion of Umbilical Cord Blood-Derived Hematopoietic Stem Cells. Indian Journal of Hematology and Blood Transfusion 2016; 32(1): 67 doi: 10.1007/s12288-015-0545-y
|
92 |
Dietmar Pils, Peter Horak, Andreas Gleiss, Cornelia Sax, Gerhild Fabjani, Volker J. Moebus, Christoph Zielinski, Alexander Reinthaller, Robert Zeillinger, Michael Krainer. Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinoma. Cancer 2005; 104(11): 2417 doi: 10.1002/cncr.21538
|
93 |
Armando Di Palo, Chiara Siniscalchi, Rita Polito, Ersilia Nigro, Aniello Russo, Aurora Daniele, Nicoletta Potenza. microRNA‐377‐3p downregulates the oncosuppressor T‐cadherin in colorectal adenocarcinoma cells. Cell Biology International 2021; 45(8): 1797 doi: 10.1002/cbin.11605
|
94 |
Pooneh Mokarram, Mehrdad Asghari Estiar, Hassan Ashktorab. Epigenetics Territory and Cancer. 2015; : 373 doi: 10.1007/978-94-017-9639-2_13
|
95 |
Jie Wang, Zhiqiang Zhu, Hongwei Ma. Label-Free Real-Time Detection of DNA Methylation Based on Quartz Crystal Microbalance Measurement. Analytical Chemistry 2013; 85(4): 2096 doi: 10.1021/ac3026724
|
96 |
Nora Sahnane, Francesca Magnoli, Barbara Bernasconi, Maria Grazia Tibiletti, Chiara Romualdi, Monica Pedroni, Maurizio Ponz de Leon, Giulia Magnani, Luca Reggiani-Bonetti, Lucio Bertario, Stefano Signoroni, Carlo Capella, Fausto Sessa, Daniela Furlan. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer. Clinical Epigenetics 2015; 7(1) doi: 10.1186/s13148-015-0165-2
|
97 |
Christian Gerecke, Fabian Schumacher, Alexander Edlich, Alexandra Wetzel, Guy Yealland, Lena Katharina Neubert, Bettina Scholtka, Thomas Homann, Burkhard Kleuser. Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor CDKN1A in colon cancer cells. Oncotarget 2018; 9(67): 32822 doi: 10.18632/oncotarget.25999
|
98 |
Imen Miladi-Abdennadher, Rania Abdelmaksoud-Damak, Lobna Ayadi, Abdelmajid Khabir, Foued Frikha, Lamia Kallel, Ali Amouri, Mounir Frikha, Tahia Sellami-Boudawara, Ali Gargouri, Raja Mokdad-Gargouri. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma. Tumor Biology 2010; 31(5): 503 doi: 10.1007/s13277-010-0063-3
|
99 |
Bryson W. Katona, John P. Lynch. Physiology of the Gastrointestinal Tract. 2018; : 1615 doi: 10.1016/B978-0-12-809954-4.00066-9
|
100 |
Mahalakshmi Palani, Sabarinathan Devan, R. Arunkumar, A. J. Vanisree. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population. Medical Oncology 2011; 28(S1): 445 doi: 10.1007/s12032-010-9671-4
|
101 |
Zdenko Herceg, Paolo Boffetta. Environmental Factors, Genes, and the Development of Human Cancers. 2010; : 153 doi: 10.1007/978-1-4419-6752-7_7
|
102 |
Wenzheng Yuan, Jinhuang Chen, Yan Shu, Sanguang Liu, Liang Wu, Jintong Ji, Zhengyi Liu, Qiang Tang, Zili Zhou, Yifeng Cheng, Bin Jiang, Xiaogang Shu, John Green. Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis. PLOS ONE 2017; 12(9): e0184959 doi: 10.1371/journal.pone.0184959
|
103 |
Yutaka Suehiro, Chi Wai Wong, Lucian R. Chirieac, Yutaka Kondo, Lanlan Shen, C. Renee Webb, Yee Wai Chan, Annie S.Y. Chan, Tsun Leung Chan, Tsung-Teh Wu, Asif Rashid, Yuichiro Hamanaka, Yuji Hinoda, Rhonda L. Shannon, Xuemei Wang, Jeffrey Morris, Jean-Pierre J. Issa, Siu Tsan Yuen, Suet Yi Leung, Stanley R. Hamilton. Epigenetic-Genetic Interactions in theAPC/WNT, RAS/RAF, andP53Pathways in Colorectal Carcinoma. Clinical Cancer Research 2008; 14(9): 2560 doi: 10.1158/1078-0432.CCR-07-1802
|
104 |
Gašper Berginc, Matej Bračko, Damjan Glavač. MS-MLPA Reveals Progressive Age-Dependent Promoter Methylation of Tumor Suppressor Genes and Possible Role ofIGSF4Gene in Colorectal Carcinogenesis of Microsatellite Instable Tumors. Cancer Investigation 2010; 28(1): 94 doi: 10.3109/07357900902849673
|
105 |
Xiaolong Shi, Chao Tang, Dequan Zhou, Hong Zhao, Zuhong Lu. Multiplex detection of CpG methylation using microarray combining with target-selection-padlock probe. Clinica Chimica Acta 2010; 411(17-18): 1187 doi: 10.1016/j.cca.2010.03.026
|
106 |
Zhu Wang, Xin Yuan, Nanlin Jiao, Hui Zhu, Youwei Zhang, Jiandong Tong. CDH13 and FLBN3 Gene Methylation are Associated with Poor Prognosis in Colorectal Cancer. Pathology & Oncology Research 2012; 18(2): 263 doi: 10.1007/s12253-011-9437-0
|
107 |
Maedeh Mohsenzadeh, Rouhallah Najjar Sadeghi, Mohsen Vahedi, Fereshteh Kamani, Mehrdad Hashemi, Hamid Asadzadeh, Mohammad Reza Zali. Promoter hypermethylation of RAR-β tumor suppressor gene in gastric carcinoma: Association with histological type and clinical outcomes. Cancer Biomarkers 2017; 20(1): 7 doi: 10.3233/CBM-160331
|
108 |
Mary Ann S. Crissey, Rong-Jun Guo, Franz Fogt, Hong Li, Jonathan P. Katz, Debra G. Silberg, Eun Ran Suh, John P. Lynch. The Homeodomain Transcription Factor Cdx1 Does Not Behave as an Oncogene in Normal Mouse Intestine. Neoplasia 2008; 10(1): 8 doi: 10.1593/neo.07703
|
109 |
Weiping Ye, Pingping Xu, Robert Jen, Eric Feng, Saiyi Zhong, Hong Li, Shu-Hong Lin, Jie-Yu Liu, Young C. Lin. Zeranol Down-Regulates p53 Expression in Primary Cultured Human Breast Cancer Epithelial Cells through Epigenetic Modification. International Journal of Molecular Sciences 2011; 12(3): 1519 doi: 10.3390/ijms12031519
|
110 |
Jian Yu, Tongyu Zhu, Zhirou Wang, Hongyu Zhang, Ziliang Qian, Huili Xu, Baomei Gao, Wei Wang, Lianping Gu, Jun Meng, Jina Wang, Xu Feng, Yixue Li, Xuebiao Yao, Jingde Zhu. A Novel Set of DNA Methylation Markers in Urine Sediments for Sensitive/Specific Detection of Bladder Cancer. Clinical Cancer Research 2007; 13(24): 7296 doi: 10.1158/1078-0432.CCR-07-0861
|
111 |
Maté Ongenaert, G Bea A Wisman, Haukeline H Volders, Alice J Koning, Ate GJ van der Zee, Wim van Criekinge, Ed Schuuring. Discovery of DNA methylation markers in cervical cancer using relaxation ranking. BMC Medical Genomics 2008; 1(1) doi: 10.1186/1755-8794-1-57
|
112 |
Ho-Jin Kang, Eun-Jeong Kim, Byoung-Gwon Kim, Chang-Hun You, Sang-Yong Lee, Dong-Il Kim, Young-Seoub Hong. Quantitative Analysis of Cancer-associated Gene Methylation Connected to Risk Factors in Korean Colorectal Cancer Patients. Journal of Preventive Medicine & Public Health 2012; 45(4): 251 doi: 10.3961/jpmph.2012.45.4.251
|
113 |
Y Hori, Y Oda, K Kiyoshima, Y Yamada, Y Nakashima, S Naito, M Tsuneyoshi. Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis. The Journal of Pathology 2007; 212(2): 218 doi: 10.1002/path.2176
|
114 |
Hsin-Yi Chen, Yu-Min Lin, Hsiang-Ching Chung, Yaw-Dong Lang, Ching-Jung Lin, John Huang, Wei-Chi Wang, Feng-Mao Lin, Zhen Chen, Hsien-Da Huang, John Y.-J. Shyy, Jin-Tung Liang, Ruey-Hwa Chen. miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4. Cancer Research 2012; 72(14): 3631 doi: 10.1158/0008-5472.CAN-12-0667
|
115 |
Majid Eslami, Bahman Yousefi, Parviz Kokhaei, Maral Hemati, Zahra Rasouli Nejad, Vahid Arabkari, Afshin Namdar. Importance of probiotics in the prevention and treatment of colorectal cancer. Journal of Cellular Physiology 2019; 234(10): 17127 doi: 10.1002/jcp.28473
|
116 |
Shuji Ogino, Takako Kawasaki, Akiyo Ogawa, Gregory J. Kirkner, Massimo Loda, Charles S. Fuchs. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype. Human Pathology 2007; 38(4): 585 doi: 10.1016/j.humpath.2006.09.014
|
117 |
M. Hachana, M. Trimeche, S. Ziadi, K. Amara, S. Korbi. Evidence for a role of the Simian Virus 40 in human breast carcinomas. Breast Cancer Research and Treatment 2009; 113(1): 43 doi: 10.1007/s10549-008-9901-z
|
118 |
Lele Song, Yuemin Li. The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis. Stem Cell Reviews and Reports 2016; 12(5): 573 doi: 10.1007/s12015-016-9672-6
|
119 |
Wael Mohamed Abdel-Rahman, Taina Tuulikki Nieminen, Soheir Shoman, Saad Eissa, Paivi Peltomaki. Loss of p15INK4bExpression in Colorectal Cancer is Linked to Ethnic Origin. Asian Pacific Journal of Cancer Prevention 2014; 15(5): 2083 doi: 10.7314/APJCP.2014.15.5.2083
|
120 |
Eva Karamitopoulou, Inti Zlobec, Anna Koumarianou, Efstratios S. Patsouris, George Peros, Alessandro Lugli. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups. Cancer 2010; 116(19): 4474 doi: 10.1002/cncr.25304
|
121 |
MUNAWWAR ALI KHAN, ARIF HUSSAIN, MADHUMITHA KEDHARI SUNDARAM, USAMA ALALAMI, DIAN GUNASEKERA, LAVEENA RAMESH, AMINA HAMZA, UZMA QURAISHI. (−)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Oncology Reports 2015; 33(4): 1976 doi: 10.3892/or.2015.3802
|
122 |
Sanjay Kakar, Guoren Deng, Vaibhav Sahai, Koji Matsuzaki, Hirofumi Tanaka, Soichuro Miura, Young S. Kim. Clinicopathologic Characteristics, CpG Island Methylator Phenotype, and BRAF Mutations in Microsatellite-Stable Colorectal Cancers Without Chromosomal Instability. Archives of Pathology & Laboratory Medicine 2008; 132(6): 958 doi: 10.5858/2008-132-958-CCCIMP
|
123 |
F. Javier Carmona, Manel Esteller. Metastasis of Colorectal Cancer. Cancer Metastasis - Biology and Treatment 2010; 14: 101 doi: 10.1007/978-90-481-8833-8_4
|
124 |
Alexandra V. Andreeva, Mikhail A. Kutuzov. Cadherin 13 in cancer. Genes, Chromosomes and Cancer 2010; 49(9): 775 doi: 10.1002/gcc.20787
|
125 |
Hai-Xing Chen, Zi-Ying Yuan, Ke-Xiang Wu, Chen Liu, Qing-Dong Mao, Bao-Guo He, Hao Yuan. The study of methylation and single nucleotide polymorphisms of cancer-related genes in patients with early-stage ulcerative colitis. Scandinavian Journal of Gastroenterology 2019; 54(4): 427 doi: 10.1080/00365521.2019.1594355
|
126 |
Samson Mani, Kasia Szymańska, Cyrille Cuenin, David Zaridze, Karen Balassiano, Sheila C.S. Lima, Elena Matos, Alexander Daudt, Sergio Koifman, Victor Wunsch Filho, Ana M.B. Menezes, Maria Paula Curado, Gilles Ferro, Thomas Vaissière, Bakary Sylla, Massimo Tommasino, Luis Felipe Ribeiro Pinto, Paolo Boffetta, Pierre Hainaut, Paul Brennan, Zdenko Herceg. DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract. Epigenetics 2012; 7(3): 270 doi: 10.4161/epi.7.3.19306
|
127 |
Frank I. Scott, John P. Lynch. Molecular Pathology of Neoplastic Gastrointestinal Diseases. Molecular Pathology Library 2013; 7: 3 doi: 10.1007/978-1-4614-6015-2_1
|
128 |
Kenneth K.W. To, Wing W. Leung, Simon S.M. Ng. A novel miR‐203‐DNMT3b‐ABCG2 regulatory pathway predisposing colorectal cancer development. Molecular Carcinogenesis 2017; 56(2): 464 doi: 10.1002/mc.22508
|
129 |
Daniel Weiss, Tuerker Basel, Florian Sachse, Andreas Braeuninger, Claudia Rudack. Promoter methylation of cyclin A1 is associated with human papillomavirus 16 induced head and neck squamous cell carcinoma independently of p53 mutation. Molecular Carcinogenesis 2011; 50(9): 680 doi: 10.1002/mc.20798
|
130 |
Rupal Sinha, Showket Hussain, Ravi Mehrotra, R. Suresh Kumar, Kapil Kumar, Pankaj Pande, Dinesh Chandra Doval, Seemi Farhat Basir, Mausumi Bharadwaj, Hassan Ashktorab. Kras Gene Mutation and RASSF1A, FHIT and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population. PLoS ONE 2013; 8(4): e60142 doi: 10.1371/journal.pone.0060142
|
131 |
Jingde Zhu, Xuebiao Yao. Use of DNA methylation for cancer detection: Promises and challenges. The International Journal of Biochemistry & Cell Biology 2009; 41(1): 147 doi: 10.1016/j.biocel.2008.09.003
|
132 |
Riadh Ben Gacem, Mohamed Hachana, Sonia Ziadi, Soumaya Ben Abdelkarim, Samir Hidar, Mounir Trimeche. Clinicopathologic significance of DNA methyltransferase 1, 3a, and 3b overexpression in Tunisian breast cancers. Human Pathology 2012; 43(10): 1731 doi: 10.1016/j.humpath.2011.12.022
|
133 |
M S Kim, X Chang, K Yamashita, J K Nagpal, J H Baek, G Wu, B Trink, E A Ratovitski, M Mori, D Sidransky. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene 2008; 27(25): 3624 doi: 10.1038/sj.onc.1211021
|
134 |
Marloes Berkhout, Iris D Nagtegaal, Sandra J B Cornelissen, Marieke M G Dekkers, Fred J J M van de Molengraft, Wilbert H M Peters, Fokko M Nagengast, J Han J M van Krieken, Judith W M Jeuken. Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas. Modern Pathology 2007; 20(12): 1253 doi: 10.1038/modpathol.3800952
|
135 |
Shumaila M Bilgrami, Sohail A Qureshi, Shahid Pervez, Farhat Abbas. Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer. SpringerPlus 2014; 3(1) doi: 10.1186/2193-1801-3-178
|